Free Trial

Insmed (INSM) News Today

Insmed logo
$70.44 +1.03 (+1.48%)
(As of 12/20/2024 05:31 PM ET)
Insmed Incorporated stock logo
Principal Financial Group Inc. Has $136.65 Million Holdings in Insmed Incorporated (NASDAQ:INSM)
Principal Financial Group Inc. lifted its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 12.9% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,871,890 shares of the biopharmaceutical compan
Insmed Incorporated stock logo
Insider Selling: Insmed Incorporated (NASDAQ:INSM) CEO Sells 18,750 Shares of Stock
Insmed Incorporated (NASDAQ:INSM - Get Free Report) CEO William Lewis sold 18,750 shares of the stock in a transaction on Thursday, December 19th. The stock was sold at an average price of $69.91, for a total value of $1,310,812.50. Following the completion of the transaction, the chief executive officer now owns 384,960 shares in the company, valued at approximately $26,912,553.60. This represents a 4.64 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Insmed Incorporated stock logo
Tidal Investments LLC Buys 19,696 Shares of Insmed Incorporated (NASDAQ:INSM)
Tidal Investments LLC boosted its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 447.0% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,102 shares of the biopharmaceutical company's stock after pur
Insmed Incorporated stock logo
Geode Capital Management LLC Purchases 172,664 Shares of Insmed Incorporated (NASDAQ:INSM)
Geode Capital Management LLC grew its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 4.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,813,384 shares of the biopharmaceutical co
Insmed Incorporated stock logo
Orion Portfolio Solutions LLC Boosts Stock Position in Insmed Incorporated (NASDAQ:INSM)
Orion Portfolio Solutions LLC boosted its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 48.5% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 28,087 shares of the biopharmaceutical company's stock after purchasing
Insmed Incorporated stock logo
Insmed Incorporated (NASDAQ:INSM) Given Consensus Recommendation of "Buy" by Analysts
Insmed Incorporated (NASDAQ:INSM - Get Free Report) has received a consensus rating of "Buy" from the sixteen ratings firms that are currently covering the company, Marketbeat Ratings reports. Sixteen equities research analysts have rated the stock with a buy recommendation. The average 12-month p
Insmed Incorporated stock logo
Wellington Management Group LLP Boosts Position in Insmed Incorporated (NASDAQ:INSM)
Wellington Management Group LLP grew its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 2.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 962,459 shares of the biopharmaceutical company's stock after ac
Should You Invest in Insmed Incorporated (INSM)?
Insmed Incorporated stock logo
Castleark Management LLC Increases Stake in Insmed Incorporated (NASDAQ:INSM)
Castleark Management LLC increased its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 159.9% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 43,300 shares of the biopharmaceutical company's stock after buying an additiona
Insmed Incorporated stock logo
Two Sigma Advisers LP Has $28.67 Million Stock Holdings in Insmed Incorporated (NASDAQ:INSM)
Two Sigma Advisers LP lifted its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 32.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 392,700 shares of the bioph
Insmed Incorporated stock logo
Soros Fund Management LLC Boosts Stock Holdings in Insmed Incorporated (NASDAQ:INSM)
Soros Fund Management LLC grew its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 1.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 478,601 shares of the biopharmaceutical company's stock afte
Insmed Incorporated stock logo
Insmed Incorporated (NASDAQ:INSM) Shares Sold by Point72 Asset Management L.P.
Point72 Asset Management L.P. decreased its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 94.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 315,151 shares of the biopharmaceutical company's stock after sellin
Insmed Incorporated stock logo
Readystate Asset Management LP Reduces Holdings in Insmed Incorporated (NASDAQ:INSM)
Readystate Asset Management LP reduced its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 97.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 211,789 shares of the biopharmaceutica
Insmed Incorporated stock logo
RTW Investments LP Decreases Position in Insmed Incorporated (NASDAQ:INSM)
RTW Investments LP trimmed its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 10.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,272,008 shares of the biopharmaceutical company's sto
Insmed Incorporated stock logo
Insmed Incorporated (NASDAQ:INSM) Shares Purchased by Polar Asset Management Partners Inc.
Polar Asset Management Partners Inc. increased its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 217.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 57,500 shares of the biopha
Insmed Incorporated stock logo
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Stock Holdings in Insmed Incorporated (NASDAQ:INSM)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 65.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor ow
Insmed Incorporated stock logo
Parkman Healthcare Partners LLC Has $2.59 Million Holdings in Insmed Incorporated (NASDAQ:INSM)
Parkman Healthcare Partners LLC decreased its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 55.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,433 shares of the biopharmac
Insmed Incorporated stock logo
171,704 Shares in Insmed Incorporated (NASDAQ:INSM) Bought by Patient Square Capital LP
Patient Square Capital LP bought a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm bought 171,704 shares of the biopharmaceutical company's stock, valued at approximatel
Insmed Incorporated stock logo
Bamco Inc. NY Buys Shares of 40,500 Insmed Incorporated (NASDAQ:INSM)
Bamco Inc. NY purchased a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 40,500 shares of the biopharmaceutical company's stock, valued at approximately $2,956,000.
Insmed Incorporated stock logo
Cerity Partners LLC Grows Stock Holdings in Insmed Incorporated (NASDAQ:INSM)
Cerity Partners LLC increased its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 513.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 21,348 shares of the biophar
Insmed Incorporated stock logo
HighVista Strategies LLC Lowers Stock Position in Insmed Incorporated (NASDAQ:INSM)
HighVista Strategies LLC cut its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 64.2% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 45,447 shares of the biopharmaceutical company's stock aft
Insmed Incorporated stock logo
Cinctive Capital Management LP Sells 114,851 Shares of Insmed Incorporated (NASDAQ:INSM)
Cinctive Capital Management LP lowered its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 78.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 30,706 shares of the biopharmaceuti
Insmed Incorporated stock logo
Erste Asset Management GmbH Invests $3.45 Million in Insmed Incorporated (NASDAQ:INSM)
Erste Asset Management GmbH acquired a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund acquired 47,600 shares of the biopharmaceutical company's stock, valued at approximately $3,450,000. A
Insmed Incorporated stock logo
Bellevue Group AG Reduces Holdings in Insmed Incorporated (NASDAQ:INSM)
Bellevue Group AG reduced its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 48.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 525,434 shares of the biopharmaceutical company's stock after selling 496,266 shares
Insmed Incorporated stock logo
Insmed Incorporated (NASDAQ:INSM) Holdings Raised by Eventide Asset Management LLC
Eventide Asset Management LLC increased its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 34.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 906,395 shares of the biopharmac
Insmed Incorporated stock logo
Insmed Incorporated (NASDAQ:INSM) is Vestal Point Capital LP's Largest Position
Vestal Point Capital LP increased its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 113.3% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 1,600,000 shares of the biopharmaceutical company's stock after purchasing an additional 850,
Insmed Incorporated stock logo
Insmed Incorporated (NASDAQ:INSM) is Suvretta Capital Management LLC's 3rd Largest Position
Suvretta Capital Management LLC reduced its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 35.1% during the third quarter, according to its most recent filing with the SEC. The fund owned 1,635,709 shares of the biopharmaceutical company's stock after selling 886,091 shares during the
Insmed Incorporated stock logo
Insmed Incorporated (NASDAQ:INSM) Shares Bought by Ally Bridge Group NY LLC
Ally Bridge Group NY LLC increased its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 16.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 150,833 shares of the bi
Insmed Incorporated stock logo
Insmed Incorporated (NASDAQ:INSM) is Acuta Capital Partners LLC's 4th Largest Position
Acuta Capital Partners LLC raised its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 49.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 107,500 shares of the biopharmaceutical company's s
Insmed Incorporated stock logo
Charles Schwab Investment Management Inc. Purchases 137,670 Shares of Insmed Incorporated (NASDAQ:INSM)
Charles Schwab Investment Management Inc. raised its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 10.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,444,266 shares of t
Insmed Incorporated stock logo
Qsemble Capital Management LP Purchases Shares of 23,155 Insmed Incorporated (NASDAQ:INSM)
Qsemble Capital Management LP acquired a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 23,155 shares of
Insmed Incorporated stock logo
Natixis Advisors LLC Makes New $1.53 Million Investment in Insmed Incorporated (NASDAQ:INSM)
Natixis Advisors LLC bought a new stake in Insmed Incorporated (NASDAQ:INSM - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 20,894 shares of the biopharmaceutical company's stock, valued at approximately $1,525,000. Several
Insmed Incorporated stock logo
Loomis Sayles & Co. L P Has $88.34 Million Holdings in Insmed Incorporated (NASDAQ:INSM)
Loomis Sayles & Co. L P decreased its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 1.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,210,187 shares of th
Insmed Incorporated stock logo
251,739 Shares in Insmed Incorporated (NASDAQ:INSM) Purchased by Westfield Capital Management Co. LP
Westfield Capital Management Co. LP bought a new position in Insmed Incorporated (NASDAQ:INSM - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 251,739 shares of the biopharmaceutical company's stock, valued a
Insmed Incorporated stock logo
Algert Global LLC Reduces Stock Holdings in Insmed Incorporated (NASDAQ:INSM)
Algert Global LLC trimmed its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 49.5% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 81,501 shares of the biopharmaceutical company's stock after selling 79,874 shares during the period.
Insmed Incorporated stock logo
Intech Investment Management LLC Invests $3.40 Million in Insmed Incorporated (NASDAQ:INSM)
Intech Investment Management LLC bought a new stake in Insmed Incorporated (NASDAQ:INSM - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 46,593 shares of the biopharmac
Insmed Incorporated stock logo
B. Metzler seel. Sohn & Co. Holding AG Invests $767,000 in Insmed Incorporated (NASDAQ:INSM)
B. Metzler seel. Sohn & Co. Holding AG acquired a new position in Insmed Incorporated (NASDAQ:INSM - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 10,510 shares of the biopharmaceutica
Insmed price target raised to $83 from $74 at JPMorgan
Insmed Incorporated stock logo
Eagle Asset Management Inc. Sells 51,455 Shares of Insmed Incorporated (NASDAQ:INSM)
Eagle Asset Management Inc. lessened its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 16.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 263,235 shares of the biopharmaceutical company's stock after selling
Insmed Incorporated stock logo
Insmed (NASDAQ:INSM) Price Target Raised to $83.00 at JPMorgan Chase & Co.
JPMorgan Chase & Co. boosted their price target on shares of Insmed from $74.00 to $83.00 and gave the stock an "overweight" rating in a report on Friday.
Insmed Incorporated stock logo
Swiss National Bank Boosts Stake in Insmed Incorporated (NASDAQ:INSM)
Swiss National Bank increased its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 9.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 302,500 shares of the
Insmed’s Strategic Growth and Market Potential Drive Buy Recommendation
Insmed Incorporated stock logo
Insmed Incorporated (NASDAQ:INSM) Stock Holdings Lifted by Jennison Associates LLC
Jennison Associates LLC lifted its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 3.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 769,253 shares of the biopharmace
Get Insmed News Delivered to You Automatically

Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter.

Did You See Trump’s Bombshell Exec. Order 001? (Ad)

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

I put all the details together for you here — but please hurry. 

INSM Media Mentions By Week

INSM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

INSM
News Sentiment

0.95

0.61

Average
Medical
News Sentiment

INSM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

INSM Articles
This Week

7

8

INSM Articles
Average Week

Get Insmed News Delivered to You Automatically

Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:INSM) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners